Literature DB >> 30528746

The Hippocampus in Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in Depression.

Darren W Roddy1, Chloe Farrell2, Kelly Doolin2, Elena Roman2, Leonardo Tozzi3, Thomas Frodl4, Veronica O'Keane2, Erik O'Hanlon5.   

Abstract

BACKGROUND: Hippocampal volume reduction is the most replicated finding in neuroimaging studies of major depressive disorder (MDD). Varying hippocampal volume definition is a well-established problem in this field. Given that hippocampal function can be mapped onto anatomically defined substructures and that detailed examination of substructure volumes is now possible, we examined different hippocampal composite measures in MDD to look for hippocampal markers of MDD.
METHODS: Magnetic resonance imaging brain scans were compared between 80 patients with a range of MDD duration and 83 healthy control subjects. High-resolution T1-weighted and T2-weighted-fluid-attenuated inversion recovery magnetic resonance images were examined using the automated hippocampal substructure module in FreeSurfer 6.0. Between-group volumetric assessments were performed at substructure and composite substructures levels.
RESULTS: Patients with MDD showed a bilateral pattern of volume reduction in principal hippocampal substructures: the cornu ammonis (CA1-CA4), dentate gyrus, and subiculum. Changes were more pronounced on the left of these structures and in recurrent depression. CA2 to CA4 were the only substructures reduced in first-presentation depression. Overall changes were most marked in the left CA1, and CA1 volume was a predictor of illness duration.
CONCLUSIONS: Hippocampal involvement in MDD is confined to principal substructures only. Differences between patients with MDD and healthy control subjects increased with progressively restricted hippocampal definitions, with the left CA1 emerging as a potential marker of MDD. Changes were more extensive in patients with recurrent, as opposed to first-presentation, MDD, suggesting a hippocampal disease process. These findings identify core hippocampal regions in the pathology of MDD, suggesting a potential marker of disease progression in MDD.
Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; First-presentation; FreeSurfer; Hippocampus; Recurrent; Substructure

Mesh:

Year:  2018        PMID: 30528746     DOI: 10.1016/j.biopsych.2018.08.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  57 in total

1.  Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.

Authors:  Nikita Nogovitsyn; Meghan Muller; Roberto Souza; Stefanie Hassel; Stephen R Arnott; Andrew D Davis; Geoffrey B Hall; Jacqueline K Harris; Mojdeh Zamyadi; Paul D Metzak; Zahinoor Ismail; Jonathan Downar; Sagar V Parikh; Claudio N Soares; Jean M Addington; Roumen Milev; Kate L Harkness; Benicio N Frey; Raymond W Lam; Stephen C Strother; Susan Rotzinger; Sidney H Kennedy; Glenda M MacQueen
Journal:  Neuropsychopharmacology       Date:  2019-10-14       Impact factor: 7.853

2.  Parcellation of the human hippocampus based on gray matter volume covariance: Replicable results on healthy young adults.

Authors:  Ruiyang Ge; Paul Kot; Xiang Liu; Donna J Lang; Jane Z Wang; William G Honer; Fidel Vila-Rodriguez
Journal:  Hum Brain Mapp       Date:  2019-05-22       Impact factor: 5.038

3.  Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors.

Authors:  Hui Ma; Chenyang Li; Jinpeng Wang; Xiaochen Zhang; Mingyue Li; Rong Zhang; Zhuo Huang; Yong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

4.  Socioeconomic Disparities in Chronic Physiologic Stress Are Associated With Brain Structure in Children.

Authors:  Emily C Merz; Pooja M Desai; Elaine A Maskus; Samantha A Melvin; Rehan Rehman; Sarah D Torres; Jerrold Meyer; Xiaofu He; Kimberly G Noble
Journal:  Biol Psychiatry       Date:  2019-06-12       Impact factor: 13.382

5.  Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice.

Authors:  Dayalan Sampath; Joshua McWhirt; Monica Sathyanesan; Samuel S Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-08-24       Impact factor: 5.067

6.  Abnormal hippocampal substructure volume in insomnia disorder.

Authors:  Longmao Chen; Ziqiang Shao; Wangrui Lei; Yan Xu; Shuang Liu; Min Zhang; Shicong Wang; Xinwen Wen; Dahua Yu; Kai Yuan
Journal:  Brain Imaging Behav       Date:  2021-09-14       Impact factor: 3.978

7.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

8.  Brain Activation during Memory Retrieval is Associated with Depression Severity in Women.

Authors:  Jennifer T Sneider; Julia E Cohen-Gilbert; Derek A Hamilton; Anna M Seraikas; Emily N Oot; Eleanor M Schuttenberg; Lisa D Nickerson; Marisa M Silveri
Journal:  Psychiatry Res Neuroimaging       Date:  2020-10-09       Impact factor: 2.376

9.  Resolving heterogeneity in schizophrenia through a novel systems approach to brain structure: individualized structural covariance network analysis.

Authors:  Zhaowen Liu; Lena Palaniyappan; Xinran Wu; Kai Zhang; Jiangnan Du; Qi Zhao; Chao Xie; Yingying Tang; Wenjun Su; Yarui Wei; Kangkang Xue; Shaoqiang Han; Shih-Jen Tsai; Ching-Po Lin; Jingliang Cheng; Chunbo Li; Jijun Wang; Barbara J Sahakian; Trevor W Robbins; Jie Zhang; Jianfeng Feng
Journal:  Mol Psychiatry       Date:  2021-07-28       Impact factor: 15.992

Review 10.  Widespread Morphometric Abnormalities in Major Depression: Neuroplasticity and Potential for Biomarker Development.

Authors:  Cynthia H Y Fu; Yong Fan; Christos Davatzikos
Journal:  Neuroimaging Clin N Am       Date:  2019-11-08       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.